|Age:||2 to 7 years old|
|Keywords:||Duchenne Muscular Dystrophy, DMD, nonsense mutation Duchenne Muscular Dystrophy, nmDMD|
|Type:||Drug study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.